ABBVIE, INC. for ABBVIE INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.5376, Build Back Better Act - provisions related to corporate taxes, Medicare, and prescription drug pricing Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD tax framework
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Copyright/Patent/Trademark CPT
H.R.2891, Preserve Access to Affordable Generics and Biosimilars Act - all H.R.2873, Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 - all H.R.2883, Stop Stalling Access to Affordable Medications - all H.R.2884, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act - all Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Health Issues HCR
H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act - all H.R. 19, Lower Costs, More Cures Act - all H.R. 5260, Reduced Costs and Continued Cures Act - all H.R. 5801, Help Ensure Lower Patient Copays Act - all S. 2164, Lower Costs, More Cures Act of 2021 - all Drug cost and pricing policy issues Patient affordability issues Policy proposals relating to clinical trial diversity Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021 & 2022; Notice Requirement for Non-Federal Governmental Plans proposed rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
H.R. 3684, Infrastructure Investment and Jobs Act - provisions related to Medicare Part B vial size refund policy Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (CMS 2482-F)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.